In addition, the tumor suppressive role of miR-663a was demonstrated in colorectal cancer cells [16], prostate cancer and especially in glioblastoma, in which miR-663a targeted PIK3CD and served as a prognostic biomarker [20]. This evidence concerns the gene PIK3CD and neoplasm.